S. Thalhammer, J. Geigl, A. Zink, H. Meimberg, M. Hennemeyer, W. M. Heckl
The atomic force microscope (AFM) can be used to visualize and to manipulate biological material with relative ease and high resolution. Here we show the use the AFM in cytogenetics. Chromosomal...
Westhoff, G., Rau, R., Zink, A.
Objectives. To investigate the influence of smoking on disease activity, drug need and radiographic joint damage in RF-positive and -negative patients with early RA. Methods. Baseline and 3-yr...
Westhoff, G., Buttgereit, F., Gromnica-Ihle, E., Zink, A.
Objective. To describe the association between morning stiffness (MS) and early retirement in patients with early RA. Methods. The study used data from a prospective RA cohort of 916 RA patients with...
S. Thalhammer, W. M. Heckl, A. Zink, A. G. Nerlich
In this study, we present a new technique for the structural analysis of the collagen compound in historic tissues. We therefore used atomic force microscopy (AFM), a new high resolution technique...
Zink, A., Prosch, M., Korte, O., Kellermann, C., Linz, B.
DE 102007007830 A1 UPAB: 20080912 NOVELTY - The device has a text data entry device (10) for entering text data (11a) into a data stream to provide an escape-start-sequence into the data stream. The...
Schuller, G., Wabnik, S., Grill, B., Zink, A.
WO 2008089938 A2 UPAB: 20080815 NOVELTY - The device has a coder (14) for generating a coded signal from an information signal (16). The coder is formed to generate a main channel (18a) and a sub...
Sender zum Senden von Informationsdaten und Empfaenger zum Empfangen von Informationsdaten (2006)
Prosch, M., Zink, A., Linz, B.
WO2006029665 A UPAB: 20060421 NOVELTY - A sender of information arranged in many sets comprises a device to assign mixed information to one or more of the data sets where the information indicates...
Zink, A., Fazlija, F., Fazlija, N., Korte, O.
WO2006029749 A UPAB: 20060421 NOVELTY - The information point has a device (101) for the preparation of a data structure and has specifications of various objects. Each object is allocated a defined...
Maczel, Marta, Dutour, Olivier, Ardagna, Yann, Panuel, Michel, Zink, A., G. Nerlich, Andreas, ...
Les fouilles effectuées à l'abbaye bénédictine de la Celle (Var, France) ont mis au jour les restes osseux médiévaux de 105 individus. Les résutlats des études paléopathologiques attestent...
ORTSABHAENGIGE INFORMATIONSWIEDERGABE UNTER ANPASSUNG EINES GEOGRAPHISCHEN AUSWAHLPARAMETERS (2005)
Llombart-Juan, N., Gerhaeuser, H., Korte, O., Plankenbuehler, R., Zink, A.
Verfahren und Vorrichtung zur Informationswiedergabe (2005)
Serra, M., Korte, O., Zink, A.
WO2005109245 A UPAB: 20051222 NOVELTY - The apparatus includes a device (12) for randomly selecting an information object (50) based on an adaptive probability distribution (60), to obtain a selected...
Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...
Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...
Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...
Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...
Braun, J., Baraliakos, X., Brandt, J., Listing, J., Zink, A., Alten, R., ...
Objective. Infliximab, a monoclonal antibody against tumour necrosis factor α (TNF-α), is approved in Europe for the treatment of patients with active ankylosing spondylitis (AS) who have responded...
Verfahren und Vorrichtung zur Wiedergabe von Informationen (2004)
Zink, A., Korte, O., Braumueller, D.v., Gerhaeuser, H., Plankenbuehler, R.
WO 200215147 A UPAB: 20020502 NOVELTY - The method involves determining the location, selecting a management part from a number of management parts (VTs), each with a reference to one of a number of...
Pusch, C. M., Broghammer, M., Nicholson, G. J., Nerlich, A. G., Zink, A., Kennerknecht, I., ...
Achondroplasia (ACH) is a skeletal disorder (MIM100800) with an autosomal dominant Mendelian inheritance and complete penetrance. We here report the screening of ancient bone samples for diagnostic...
Pusch, C. M., Broghammer, M., Nicholson, G. J., Nerlich, A. G., Zink, A., Kennerknecht, I., ...
Achondroplasia (ACH) is a skeletal disorder (MIM100800) with an autosomal dominant Mendelian inheritance and complete penetrance. Here we report the screening of ancient bone samples for diagnostic...
Pusch, C. M., Broghammer, M., Nicholson, G. J., Nerlich, A. G., Zink, A., Kennerknecht, I., ...
Achondroplasia (ACH) is a skeletal disorder (MIM100800) with an autosomal dominant Mendelian inheritance and complete penetrance. We here report the screening of ancient bone samples for diagnostic...
Trump, D, Farren, B, Wooding, C, Pang, JT, Besser, GM, Buchanan, KD, ...
Trap Spectroscopy and TSL in Feldspars (1996)
Visocekas, R., Tale, V., Zink, A., Spooner, N.A., Tale, I.
Many feldspars cannot be used in dosimetry and dating as they display anomalous fading of TSL due to tunnel recombination. With alkali feldspars, this effect is stronger with sanidines, with a...
Dosimetry with Feldspars and Their Infrared Emission Band (1996)
Dating of feldspars by TL and OSL is done currently by monitoring their various emissions in the spectral range from UV to yellow ('blue'). These emissions are often affected by an anomalous fading,...
Zink, A, Listing, J, Niewerth, M, Zeidler, H
OBJECTIVE—To describe current treatment of patients with rheumatoid arthritis (RA) in German rheumatology. METHODS—Data from the German rheumatological database of 1998, comprising clinical...
Zink, A, Listing, J, Klindworth, C, Zeidler, H
OBJECTIVE—To describe the aims, principles, and content of the German rheumatological database and to present data on patient mix and healthcare provision for the year 1998. METHODS—The German...
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
Rudwaleit, M, Andermann, B, Alten, R, Sorensen, H, Listing, J, Zink, A, ...
Background: The prevalence of atopic disorders in ankylosing spondylitis (AS) is unknown. AS and rheumatoid arthritis (RA) exhibit divergent T helper (Th) cell cytokine patterns.
Ankylosing spondylitis: an overview
Sieper, J, Braun, J, Rudwaleit, M, Boonen, A, Zink, A
Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in onset, progressing to radiological sacroiliitis over several years. Patients with symptomatic AS lose...
Burden and cost of illness in patients with juvenile idiopathic arthritis
Minden, K, Niewerth, M, Listing, J, Biedermann, T, Schontube, M, Zink, A
Objective: To estimate the cost of illness in an incidence based cohort of patients with juvenile idiopathic arthritis.
Listing, J, Brandt, J, Rudwaleit, M, Zink, A, Sieper, J, Braun, J
Methods: The data of a 2 year open extension study of a 12 week, double blind, randomised, placebo controlled trial, in which all patients with AS were treated with 5 mg/kg infliximab, were used to...
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
Braun, J, Brandt, J, Listing, J, Zink, A, Alten, R, Burmester, G, ...
Objective: To obtain results of the second year extension of an original 3 month randomised, placebo controlled trial (and the 1 year extension study) assessing the use of infliximab, a monoclonal...
Treatment continuation in patients receiving biological agents or conventional DMARD therapy
Zink, A, Listing, J, Kary, S, Ramlau, P, Stoyanova-Scholz, M, Babinsky, K, ...
Objective: To compare drug continuation rates in patients with rheumatoid arthritis who start on a biological agent and in a control group of patients with a change in disease modifying antirheumatic...